TheProfitWatch

FULC - Fulcrum Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.81 0.84 (9.53%) --- --- --- 0.18 (2.04%) 0.9 (10.29%) --- 0.18 (2.04%)

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.28
Diluted EPS:
-0.28
Basic P/E:
-34.4643
Diluted P/E:
-34.4643
RSI(14) 1m:
58.06
VWAP:
9.65
RVol:
0.9196

Events

Period Kind Movement Occurred At
Day Price increase day 9.7 +0.89 (+10.1%) Oct 15 14:53
1m Price increase 1m 9.52 +0.14 (+1.49%) Oct 15 14:07
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57

Related News